title: [HIV and pregnancy].
abstract: Through an optimal interdisciplinary management, it is possible to reduce the mother-to-child transmission of HIV-1 from more than 40% to less than 2%. The following are essential for this success: A risk-adapted antiviral therapy during the pregnancy and birth, a transmission prophylaxis for the new born child, delivery by Caesarean section, the early treatment of concomitant gynecological infections and abstention from breastfeeding. Unidentified HIV-positive pregnant women and inadequate support for HIV-positive pregnant women account for the majority of new HIV-1 infections in children in Germany. Hence, the HIV test should be an obligatory component of prenatal care and HIV-positive pregnant women should receive assistance at an appropriate center.
authors.affiliation: Chefarzt der Frauenklinik im Klinikum der Stadt Wolfsburg. gyn@Klinikum.Wolfsburg.de
authors.forename: K U
authors.initials: KU
authors.lastname: Petry
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001942:Breast Feeding; D002585:Cesarean Section; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission / Q000821:virology; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000453:epidemiology / Q000821:virology; D012307:Risk Factors
chemical_list: D019380:Anti-HIV Agents